The Morgridge Institute for Research located on the UW-Madison campus has landed a $20.6 million cooperative agreement from the U.S. Department of Energy?s National Nuclear Security Administration, the university announced in a news release. The funds will be used by the Morgridge Institute and local partner SHINE Medical Technologies to help support the development of a new process and manufacturing plant for molybdenum-99, a medical isotope used by thousands of patients daily in this country.
Office of Strategic Communication